Click to go to DrugInjuryLaw Home

Legal information and news about prescription drug side effects
NuvaRing Case Evaluation Ortho Evra Case Evaluation Fosamax Case Evaluation Avandia Case EvaluationKetek Case Evaluation Zelnorm Case Evaluation Meridia Case Evaluation Zocor Case Evaluation
Vytorin Case EvaluationZetia Case Evaluation Yasmin Case Evaluation Ocella Case EvaluationYAZ Case Evaluation Levaquin Case Evaluation Byetta Case Evaluation Gianvi Case Evaluation

Free Case Evaluation

Meridia Information

What is Meridia?

We are NOT accepting any new Meridia cases


Meridia Withdrawn From Market By Abbott October 2010 Per FDA Request

Meridia Recall By Abbott In October 2010 Follows FDA Request To Withdraw Drug From Market

In January 2010 the FDA announced it found an increased risk of heart attack and stroke in patients with a history of cardiovascular disease who used the weight loss medication Meridia (sibutramine), based on the agency's review of additional safety data from a large study. Given the serious nature of these recent findings, the FDA requested and Abbott Laboratories agreed to add a new "contraindication" to the package insert, or label, for Meridia.

The new Meridia label will include a contraindication which states that Meridia is not to be used in patients with a history of cardiovascular disease, including:

  • History of coronary artery disease (e.g., heart attack, angina)
  • History of stroke or transient ischemic attack (TIA)
  • History of heart arrhythmias
  • History of congestive heart failure
  • History of peripheral arterial disease
  • Uncontrolled hypertension (e.g., > 145/90 mmHg)

At the same time, the FDA said that later this year it will convene an open public advisory committee meeting to discuss Meridia’s safety profile, i.e., drug benefits vs. side effect risks, to determine if additional regulatory actions should be taken by the FDA as regards Meridia.

Meridia Recall By Abbott In October 2010 Follows FDA Request To Withdraw Drug From Market

Meridia recall in U.S. pursuant to FDA request in October 2010 due to increased risks of a stroke or cerebrovascular accident (CVA), heart attack or myocardial infarction (MI), sudden cardiac death, and other serious cardiovascular side effects caused by Meridia outweighing any benefit from use of this obesity drug.

Public Citizen Petitions FDA To Ban Abbott Diet Drug Meridia In December 2009

Public Citizen issues its second request for the recall of Meridia.  This request comes in the wake of a new study linking dangerous and potentially fatal heart-related side effects to this diet drug.

Meridia Label Change Follows FDA Review Of Heart-Related Adverse Events In SCOUT Study

The package insert for Meridia will be updated to include a contraindication for patients with cardiovascular diseases due to a SCOUT Study highlighting an association between Meridia and heart attacks, heart failure, and strokes.

September 2003: Public Citizen Adds Supplement to Petition As Meridia Side Effects Victims Increases

Public Citizen again urges FDA to ban diet drug Meridia, due to rising numbers of deaths and cardiovascular adverse effects attributable to Meridia.

Issue Of Whether FDA Should Recall Meridia Is Not "New" In 2010

As far back as March 2002 safety concerns were expressed about Meridia in the United States and Europe.

March 2002: Sibutramine (Reductil/Meridia) Sales Banned By Italian Government

Italy's Health Ministry suspended the sale of sibutramine pending investigation into adverse events associated with the drug.

Health Canada Advisory About Meridia In 2002 Follows Sales Suspension In Italy

Health Canada investigates safety of Meridia (sibutramine).

FDA Warns Abbott In 2002 About Reporting Meridia Deaths

Abbott Laboratories failed to properly report deaths of patients taking Meridia.

Meridia Sales Were Suspended In Europe For Several Months During 2002

FDA Safety Review Continues in US. Abbott still awaits a review of Meridia (sibutramine) by the U.S. Food and Drug Administration (FDA).

Meridia Class Actions

We believe that people who suffered a serious injury or death due to Meridia are better served when an individual lawsuit is filed on their behalf. A serious injury or wrongful death case should not be filed as part of any Meridia class action together with the claims of many other people who may have had different injuries caused by this diet drug.

Meridia and Legal Compensation

If you experienced serious side effects or had a loved one pass away from the use of Meridia, you may have a claim for legal compensation. Legal compensation claims involving injuries caused by the use of Meridia are made by filing a lawsuit in court. All states have statutes of limitations that determine the time period allowed to file a Meridia lawsuit.

We are NOT accepting any new Meridia cases

Drug Injury Watch: Meridia News And Commentary


  • US FDA advises that you should not stop taking any prescription medication before talking to your doctor.
  • Reports of serious drug side effects should be made to the US FDA MedWatch program.
  • The prescription drug names are registered trademarks of the respective drug companies.
  • is not affiliated with any of the drug companies, nor US FDA.
Law Offices of Thomas J. Lamb, P.A.
Lumina Station Suite 225
1908 Eastwood Road
Wilmington, NC 28403
Tel: (910) 256-2971   Fax: (910) 256-2972
Toll Free: (800) 426-9535